Aaltonen LA, Peltomäki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin JP, Järvinen H, Powell SM, Jen J, Hamilton SR, Peterson GM, Kinzler KW, Vogelstein B, Chapelle A de la:
Clues to the pathogenesis of familial colorectal cancer. Science (1993), 260: 812-814
Aarino M, Mustonen H, Mecklin J-P, Järvinen H: Features of Gastric Cancer in Hereditary Non-Polyposis Colorectal Cancer Syndrome. Int J Cancer (1997), 74: 551-555
Alemayehu A, Tomkova K, Zavodna K, Ventusova K, Krivulcik T, Bujalkova M, Bartosova Z, Fridrichova I: The role of clinical criteria, genetic and epigenetic alterations in
Alexander J, Watanabe T, Wu TT, Rashid A, Li S, Hamilton SR: Histopathological
identification of colon cancer with microsatellite instability. Am J Pathol (2001), 158: 527-535
Annie Yu HJ, Lin KM, Ota DM, Lynch HT: Hereditary nonpolyposis colorectal cancer:
preventive management. Cancer Treat Rev (2003), 29: 461-470
Auclair J, Busine MP, Navarro C, Ruano E, Montmain G, Desseigne F, Saurin JC, Lasset C, Bonadona V, Giraud S, Puisieux A, Wang Q: Systemic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing. Hum Mutat (2006), 27: 145-154
Baba S: Hereditary nonpolyposis colorectal cancer: An update. Dis Colon Rectum (1997), 40: 86-95
Bethesda Guideline Workshop (2003): Revised guidelines for hereditary non-polyposis colorectal cancer and microsatellite instability. Meeting Summary,3
rd
“International Workshop on Diagnostic Guidelines for Hereditary Non-polyposis Colorectal Cancer and Microsatellite Instability”, Bethesda 11.-13.12.2002 (Meeting summary: Umar A et al. JNCI, accepted)
Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabio C,
Lipford J, Lindblom A, Tannergard P, Boolag RJ, Goodwin AR, Ward DC, Nordenskjold M,
Fishel R, Kolodner R, Liskay RM: Mutation in the DANN mismatch repair gene homologue hMLH1 is associated wirh hereditary nonpolyposis colon cancer. Nature (1994), 368: 258-261
Buckowitz A, Knaebel HP, Benner A, Blaker H , Gebert J, Kienle P, von Knebel DM, Kloor M:
Microsatellite instability on colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases. British Journal of Cancer (2005), 92: 1746-1753
Giardiello FM, Brensinger JD, Peterson G: AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology (2001), 121: 198-213
Peel DJ, A. Ziogas, EA Fox, M. Gidea, B. Laham, E. Clements, RD Kolodner, H. Anton-Culver: Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases, J Natl Cancer Inst (2000), 92:1517-1522
Gologan A, Krasinskas A, Hunt J, Thull DL, Farkas L, Sepulveda AR:
Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability. Arch Pathol Lab Med (2005), 129:1390-1397
Grady WM: Genetic Testing for High-Risk Colon Cancer Patients. Gastroenterol (2003), 124:1574-1594
Herold, G: Innere Medizin. Köln 2004
Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M: Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature (1993), 363: 558-561
Ruszkiewicz AR, Pollett AF, Redston M, Barker MA, Baron JA, Casey GR, Dowty JG, Giles GG, Limburg P, Newcomb P, Young JP, Walsh MD, Thibodeau SN, Lindor NM, Lemarchand L, Gallinger S, Haile RW, Potter JD, Hopper JL, Jass JR: Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study.
Gastoenterology (2007), 133: 48-56
Kakar S, Smyrk TC: Signet ring cell carcinoma of the colorectum: correlation between microsatellite instability, clinicopathologic features and survival. Modern Pathology (2005), 18: 244-249
Kim H, Jen J, Vogelstein B, Hamilton SR: Clinical and pathological characteristics of sporadic colorectal carcinomas with D, NA replication errors in microsatellite sequences. Am J Pathol (1994), 145: 148-156
Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomäki P, Sistonen P, Aaltonen LA, Nyström-Lahti M, Guan XY, Zhang J, Meltzer PS, Yu JW, Kao FT, Chen DC, Cerosaletti KM, Fournier REK, Todd S, Lewis T, Leach RJ, Naylor SL, Weissenbach J, Mecklin JP, Järvinen H, Peterson GM, Hamilton SR, Green J, Jass J, Watson P, Lynch HT, Trend JM, Chapelle A de la , Kinzler KW, Vogelstein B: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell (1993), 75: 1215-1225
Müller, M: Chirurgie. Breisach am Rhein 2003
Nicolaides NC, Papadopoulos N, Liu B, Wei Y, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Dunlop MG, Hamilton SR,
Peterson GM, Chapelle A de la, Vogelstein B, Kinzler K: Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature (1994), 371: 75-80
Palombo F, Gallinari P, Iaccarino I, Lerrieri T, Hughes M, D´Arrigo A, Truong O, Hsuan JJ, Jiricny J: GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science (1995), 268: 1912-1914
Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Hamilton SR, Peterson GMB, Watson P, Lynch HT, Peltomälki P, Mecklin JP, de la Chapelle A, Kinzler KW, Vogelstein B: Mutation of a mutL homolog in hereditary colon cancer. Science (1994), 263: 1625-1629
Papadopoulos N, Nicolaides NC, Liu B, Parsons R, Lengauer C, Palombo F, D´ Arrigo A, Markowitz S, Willsoon JK, Kinzler KW, et al: Mutaions of GTBP in genetically unstable cells.
Science (1995), 268: 1857-1858
Park JG, Vasen HF, Park YJ, Park KJ, Peltomaki P, de Leon MP, Rodriguez-Bigas MA,
Lubinski J, Beck NE, Bisgaard ML, Miyaki M, Wijnen JT, Baba S, Lindblom A, Madlensky L,
Lynch HT: Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study. Int J Colorectal Dis (2002), 17: 109-114
Park JG, Vasen HF, Park YJ, Peltomaki P, Ponz de Leon M, Rodriguez-Bigas MA, Lubinski J, Beck NE, Bisgaard ML, Miyaki M, Wijnen JT, Baba S, Lynch HT: Suspected Hereditary Non-Polyposis colorectal cancer (ICG-HNPCC) criteria and results of genetic diagnosis. Dis Colon Rektum (1999), 42: 710-716
Parson R, Li GM, Longley MJ, Fang W, Papadopoulos N, Jen J, de la Chapelle A, Kinzler KW, Vogelstein B, Modrich B: Hypermutability and mismatch repair deficiency in RER+tumor cells. Cell (1993), 75: 1227-1236
Peel DJ, A. Ziogas, EA Fox, M. Gidea, B. Laham, E. Clements, RD Kolodner, H. Anton-Culver: Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases, J Natl Cancer Inst (2000), 92:1517-1522
Percesepe A, Benatti P, Roncucci L, Sassatelli R, Fante R, Ganazzi D, Bellacosa A, Genuardi M, Neri G, Viel A, Ponz De Leon M: Survival Analysis in Families Affected by Hereditary Non-Polyposis Colorectal Cancer. Int J Cancer (1997), 71: 373-376
Genomic rearrangement in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations. Cancer Lett (2007), 248: 89-95
Ponds de Leon M, Sassatelli R, Benatti P, Roncucci L: Identification of hereditary nonpolyposis colorectal cancer in the general population: the 6-year experience of a population-based registry. Cancer (1993), 71: 3493-3501
Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, et al. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome:
meeting highlights and Bethesda guidelines. J Natl Cancer Inst (1997), 89: 1758-1762
Rodriguez-Moranta F, Castells A, Andreu M, Pinol V, Castellvi-Bel S, Alenda C, Llor X,
Bujanda L. Am J Gastroenterol (2006), 101: 1104-1111
Shia J, Ellis NA, Paty PB, Nash GM, Qin J, Offit K, Zhang XM, Makowitz AJ, Nafa K, Guillem JG, Wong WD, Gerald WL, Klimstra DS: Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol (2003), 27: 1407-1417
Takemoto N, Konishi F, Yamashita K, Kojima M, Furukawa T, Miyakura Y, Shitoh K, Nagai H: The correlation of microsatellite instability and tumor-infiltrating lymphocytes in hereditary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancers: the significance of different types of lymphocyte infiltration. Jpn J Clin Oncol (2004), 34: 90-98
Terdiman JP, Gum JR, Conrad PG, Miller GA, Weinberg V, Crawley SC, et al. Efficient detection by screening for tumor microsatellite instability before germline genetic testing.
Gastroenterology (2001), 120: 21-30.
Thibodeau SN, Bren G, Schaid D: Microsatellite instability in cancer of the proximal colon.
Shia J, Ellis NA, Paty PB, Nash GM, Qin J, Offit K, Zhang X, Markowitz AJ, Nafa K, Guillem JG, Wong WD, Gerald WL, Klimstra DS: Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer. Am J Surg Pathol (2003), 27: 1407-1417
Strand M, Prolla TA, Liskay RM, Peters TD: Destabilization of tracts of simple repetitive DNA in Yeast by mutations affecting DNA mismatch repair. Nature (1993), 365: 274-276
Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindbolm A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN,
Srivastava S: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch Syndrome) and microsatellite instability. J Natl Cancer Inst (2004), 96: 261-268
Ward R, Meagher A, Tomlinson I, O´Conner T, Norrie M, Wu R, Hawkins N: Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut (2001), 48:
821-829
Warthin AS: Hereditary with reference to carcinoma. Arch Int Med (1913), 12: 546-555
Watson P, Lin KM, Rodriguez-Bigas MA, Smyrk T, Lemon S, Shashidharan M, Franklin B, Karr B, Thorson A, Lynch HT: Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. American cancer society (1998), 83: 259-266
Wolf B, Gruber S, Henglmueller S, Kappel S, Bergmann M, Wrba F, Karner-Hanusch J.:
Efficiency of the revised Bethesda guidelines (2003) for the detection of mutations on mismatch repair genes in Austrian HNPCC patients. Int J Cancer (2006), 118: 1465-1470
Xu DQ, Mattox W: Identification of a splicing enhancer in MLH1 using COMPARE, a new
assay for determination of relative RNA splicing efficiencies. Hum Mol Genet (2006), 15:
